Cargando…

Use of levosimendan in myocardial dysfunction due to sepsis

Detalles Bibliográficos
Autores principales:	Vaitsis, J, Michalopoulou, H, Thomopoulos, C, Massias, S, Stamatis, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084051/ http://dx.doi.org/10.1186/cc7329

Ejemplares similares

Hyponatremia is associated with increased mortality in patients with acute decompensated hear failure
por: Vaitsis, J, et al.
Publicado: (2009)

Effect of correction of anemia in severe congestive heart failure
por: Michalopoulou, H, et al.
Publicado: (2009)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Identification of contractility abnormalities in intensive care unit patients with sepsis using tissue Doppler imaging
por: Michalopoulou, H, et al.
Publicado: (2007)

Renal insufficiency is a powerful predictor of worse outcome in patients with acute heart failure
por: Michalopoulou, H, et al.
Publicado: (2008)

Pulmonary hypertension, right ventricular dysfunction and acute heart failure: a portentous consortium
por: Michalopoulou, HD, et al.
Publicado: (2015)

Assessment of neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury in acute heart failure patients
por: Michalopoulou, H, et al.
Publicado: (2013)

Novel biomarkers for prediction of mortality after acute exacerbation of chronic obstructive pulmonary disease
por: Michalopoulou, H, et al.
Publicado: (2013)

N-terminal pro-brain natriuretic peptide as a prognostic marker in patients with exacerbation of chronic obstructive pulmonary disease
por: Stamatis, P, et al.
Publicado: (2013)

Diastolic function abnormalities in ICU patients with chronic obstructive pulmonary disease
por: Michalopoulou, H, et al.
Publicado: (2008)

Role of inflammation in nonhemorrhagic strokes
por: Michalopoulou, H, et al.
Publicado: (2008)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Incremental power of the combination of brain natriuretic peptide and tumoral antigen carbohydrate 125 for risk stratification in patients with acute heart failure
por: Michalopoulou, H, et al.
Publicado: (2008)

Levosimendan use in critical care - a case series
por: Gibson, C, et al.
Publicado: (2015)

Myocardial dysfunction in sepsis studied with the pressure recording analytical method
por: Pratesi, F, et al.
Publicado: (2008)

Atrial fibrillation following major noncardiac thoracic surgery: significance and impact on morbidity
por: Michalopoulou, H, et al.
Publicado: (2012)

Preoperative treatment with levosimendan helps to evaluate myocardial reserves in cardiosurgical patients with chronic heart failure
por: Eremenko, A, et al.
Publicado: (2015)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Utilization of levosimendan in the cardiac ICU: case series
por: Filipescu, D, et al.
Publicado: (2009)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Levosimendan: use, cost-effectiveness and outcome in a tertiary cardiothoracic centre
por: Ranjan, A, et al.
Publicado: (2015)

Levosimendan in the emergency department: a useful tool to improve cellular perfusion
por: Devia, G, et al.
Publicado: (2015)

High sensitive troponine T as a biomarker and determinant factor of myocardial dysfunction in sepsis
por: Gonzalez Londoño, J, et al.
Publicado: (2015)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Frequency and clinical spectrum of myocardial dysfunction in severe sepsis and septic shock
por: Pulido, JN, et al.
Publicado: (2010)

Levosimendan in critically ill adults: a utilisation review
por: Aron, J, et al.
Publicado: (2013)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Systemic and regional effects of levosimendan and arginine–vaopressine in endotoxin-treated rabbits
por: Kaskos, H, et al.
Publicado: (2004)

Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients
por: Iasonidou, C, et al.
Publicado: (2004)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Levosimendan reduces pulmonary vascular resistance: clinical echocardiographic study
por: Nalos, M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_f4g53r64h7rjibu43g2iunn7eq